Skip to main content

Breast and Gynecologic Cancers

Conducts and fosters research on the prevention and early detection of breast cancer, cervix and human papillomavirus (HPV)-related cancers, endometrial cancers, ovarian cancers, and related precursor conditions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Resources

Diabetes Prevention Program Outcomes Study (DPPOS)

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Altshuler, Rachel, Ph.D. rachel.altshuler@nih.gov 240-276-5873	5E304	Program Officer \| Breast and Gynecologic Cancer
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	Brofsky, Emma, M.S.P.H. emma.brofsky@nih.gov 240-276-7532	5E314	Program Analyst \| Breast and Gynecologic Cancer
	Dimond, Eileen, R.N., M.S. eileen.dimond@nih.gov 240-276-7086	5E332	Nurse Consultant \| Breast and Gynecologic Cancer
	Frech, Maria Silvina, Ph.D., M.S. maria.frech@nih.gov 240-276-5302	5E320	Program Officer \| Breast and Gynecologic Cancer
	Heckman-Stoddard, Brandy, Ph.D., M.P.H. brandy.heckman-stoddard@nih.gov 240-276-7048	5E334	Chief \| Breast and Gynecologic Cancer Acting Chief \| Community Oncology and Prevention Trials
	Perloff, Marjorie, M.D. marjorie.perloff@nih.gov 240-276-7097	5E544	Program Officer \| Breast and Gynecologic Cancer
	Rubinstein, Wendy, M.D., Ph.D. wendy.rubinstein@nih.gov	5E436	Program Officer \| Breast and Gynecologic Cancer
	Sahasrabuddhe, Vikrant, M.B.B.S., M.P.H., Dr.P.H. vikrant.sahasrabuddhe@nih.gov 240-276-7332	5E444	Deputy Chief \| Breast and Gynecologic Cancer
	Samimi, Goli, Ph.D., M.P.H. goli.samimi@nih.gov 240-276-6582	5E336	Program Officer \| Breast and Gynecologic Cancer
	Sauter, Edward, M.D., Ph.D. edward.sauter@nih.gov 240-276-7657	5E338	Program Officer \| Breast and Gynecologic Cancer
	Streck, Brennan, Ph.D., RN, M.P.H. brennan.streck@nih.gov 240-276-7050	5E430	Program Officer \| Breast and Gynecologic Cancer Program Officer \| Community Oncology and Prevention Trials
	White, Vanessa A., M.P.H. vanessa.white@nih.gov 240-276-6163	5E524	Program Officer \| Breast and Gynecologic Cancer Program Officer \| Community Oncology and Prevention Trials
	Wood (Gunn), Kristen, B.S.N. kristen.gunn@nih.gov	5E326	Nurse Consultant \| Breast and Gynecologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Rosenbluth, Jennifer M.	University Of California, San Francisco United States	In vitro models as a window to learn how to change outcomes in women at high risk of developing breast cancer	4R01CA281361-04	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ross, Stephen	New York University School Of Medicine United States	Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress	5R01CA268521-04	Rachel Altshuler, Ph.D.
Rosser, Charles J	Cedars-Sinai Medical Center United States	A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology	5R01CA277810-03	Guillermo Marquez, Ph.D.
Rotemberg, Veronica Miriam	Sloan-Kettering Inst Can Research United States	M-ISIC: A Multimodal Open-Source International Skin Imaging Collaboration Informatics Platform for Automated Skin Cancer Detection	5U24CA264369-04	Guillermo Marquez, Ph.D.
Roth, Michael E.	Public Health Institute United States	Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant	3UG1CA189955-11S3	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Rowland, Kendrith Martin	Carle Foundation United States	Carle Cancer Center NCI Community Oncology Research Program (NCORP)	3UG1CA189861-11S1	Vanessa A. White, M.P.H.
Russell, John A	University Of Wisconsin-Madison United States	Treatment of Functional Deficits IN tongue muscles induced by radiation and chemoradiation treatment	5R37CA225608-07	Cecilia Lee, Dr.P.H., RN
Saenger, Yvonne Margaret	Albert Einstein College Of Medicine United States	Applying pathomics to establish a biosignature for aggressive skin melanoma	5R01CA260375-05	Guillermo Marquez, Ph.D.
Salami, Simpa Samuel	University Of Michigan At Ann Arbor United States	Defining the Biological Arc of Grade Group 1 Prostate Cancer	5R37CA283857-03	Guillermo Marquez, Ph.D.
Salipante, Stephen J	University Of Washington United States	Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations and methylation	1R33CA302385-01	Nicholas Hodges, Ph.D.
Salkowski, Lonie	University Of Wisconsin-Madison United States	Defining and Optimizing Critical Interpretation Skills in Screening Mammography to Improve Cancer Detection	5R37CA262110-04	Guillermo Marquez, Ph.D.
Salman, Emad	Florida Assn Of Pediatric Tumor Prog United States	The Florida Pediatric NCORP: NCI Community Oncology Research Program.	3UG1CA189973-11S1	Vanessa A. White, M.P.H.
Salvemini, Daniela	Saint Louis University United States	Fingolimod and Ozanimod for the treatment and prevention of chemobrain	5R01CA261979-04	Rachel Altshuler, Ph.D.
Sanchez, Eduardo Vilar	University Of Tx Md Anderson Can Ctr United States	Cancer Immune-Interception for Lynch Syndrome	5R01CA257375-05	Asad Umar, D.V.M., Ph.D.
Sanchez, Eduardo Vilar	University Of Tx Md Anderson Can Ctr United States	iCAN PREVENT: MD Anderson International Cancer Prevention Clinical Trials Consortium	2UG1CA242609-07	Donald Johnsey